Aclarion (NASDAQ:ACON – Get Free Report) and OneMedNet (NASDAQ:ONMDW – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations.
Earnings and Valuation
This table compares Aclarion and OneMedNet”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aclarion | $80,000.00 | 86.40 | -$7.23 million | ($7.40) | -0.32 |
| OneMedNet | $1.46 million | N/A | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of current recommendations for Aclarion and OneMedNet, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aclarion | 1 | 0 | 1 | 0 | 2.00 |
| OneMedNet | 0 | 0 | 0 | 0 | 0.00 |
Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 212.50%. Given Aclarion’s stronger consensus rating and higher probable upside, analysts plainly believe Aclarion is more favorable than OneMedNet.
Institutional & Insider Ownership
7.5% of Aclarion shares are held by institutional investors. 0.0% of Aclarion shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Aclarion and OneMedNet’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aclarion | -10,948.81% | -59.34% | -56.12% |
| OneMedNet | N/A | N/A | N/A |
Summary
Aclarion beats OneMedNet on 5 of the 9 factors compared between the two stocks.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
